Journal: Autophagy
Article Title: Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells.
doi: 10.1080/15548627.2021.1972403
Figure Lengend Snippet: Figure 5. Mem from EC rather use autophagy-mediated proteolysis to support the release of free glutamine. (A-D) Intracellular levels of (A) total converted glutamine and (B,C) glutamate only in Mem at 6 h of cell activation. (A) Levels of total converted glutamine within Mem from EC, which have been or not polyclonally activated with or without PRKAA1-dependent autophagy-mediated proteolysis blockade (BaF, E64d-PepA, or compound C). (B) Validation of the glutamate bioluminescence- based measurement by using Mem from HIVneg that have been treated with BPTES to block any glutamate conversion during their cell activation. (C) Levels of glutamate in polyclonally activated Mem for all study groups with or without PRKAA1-dependent autophagy-mediated proteolysis blockade (BaF, E64d-PepA, or compound C). (D) Chromatograms of extracted ion counts representing area under the curve quantification of glutamate and glutamine in polyclonally activated Mem in all study groups. (E) Chromatograms of extracted ion counts representing area under the curve quantification of glutamate and glutamine in non-activated (NA) Mem in all study groups. (F) Relative expression of intracellular glutamine and glutamate in activated Mem in all study groups. Of note, polyclonally activated Mem from EC and HIVneg counts required 10x dilution to avoid saturating signals. N = 6. β, symbol used for paired t-test (comparison between treated Mem and untreated control). *, symbol used for Mann-Whitney test (comparison between study groups).
Article Snippet: The primary antibodies against FOXO3 (Cell Signaling Technology, 12829S), total PRKAA1 (Cell Signaling Technology, 2532S) and p-Thr172 PRKAA1 (Cell Signaling Technology, 2531S), and ACTB/β-actin (Cell Signaling Technology, 4967S) used in western blots came from Cell Signaling Technology.
Techniques: Activation Assay, Biomarker Discovery, Blocking Assay, Expressing, Comparison, Control, MANN-WHITNEY